NDC 31722-833 – Entecavir
Entecavir Anhydrous .5 mg/1 · Tablet · Oral
Product NDC31722-833
Product details
- Brand name
- Entecavir
- Generic name
- Entecavir
- Labeler
- Camber Pharmaceuticals, Inc.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA205740
- Marketed since
- August 21, 2015
- Listing expires
- December 31, 2026
- Pharmacologic class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Active ingredients
- Entecavir Anhydrous .5 mg/1
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 31722-833-30 | 30 TABLET in 1 BOTTLE (31722-833-30) | Aug 21, 2015 |
| 31722-833-31 | 10 TABLET in 1 BLISTER PACK (31722-833-31) | Aug 21, 2015 |
| 31722-833-32 | 100 TABLET in 1 CARTON (31722-833-32) | Aug 21, 2015 |
| 31722-833-90 | 90 TABLET in 1 BOTTLE (31722-833-90) | Aug 21, 2015 |
Recalls mentioning this NDC
- D-1095-2017 Aug 23, 2017 · Class II
Failed Impurities/Degradation Specification: single unknown impurity OOS 0.33% (Limit:NMT 0.20%W/W) at the three month stability point.
Other Entecavir products
- 60687-216 Entecavir .5 mg/1 · Tablet · American Health Packaging
- 65162-449 Entecavir 1 mg/1 · Tablet, Film Coated · Amneal Pharmaceuticals LLC
- 65162-446 Entecavir .5 mg/1 · Tablet, Film Coated · Amneal Pharmaceuticals LLC
- 65862-842 Entecavir 1 mg/1 · Tablet · Aurobindo Pharma Limited
- 65862-841 Entecavir .5 mg/1 · Tablet · Aurobindo Pharma Limited
- 42291-261 Entecavir .5 mg/1 · Tablet, Film Coated · AvKARE
- 31722-834 Entecavir Anhydrous 1 mg/1 · Tablet · Camber Pharmaceuticals, Inc.
- 42494-457 Entecavir Anhydrous .5 mg/1 · Tablet · Cameron Pharmaceuticals
- 42494-458 Entecavir Anhydrous 1 mg/1 · Tablet · Cameron Pharmaceuticals
- 61442-311 Entecavir .5 mg/1 · Tablet · Carlsbad Technology, Inc.
- 69097-425 Entecavir 1 mg/1 · Tablet, Film Coated · Cipla USA Inc.
- 69097-426 Entecavir .5 mg/1 · Tablet, Film Coated · Cipla USA Inc.